241 related articles for article (PubMed ID: 33979608)
1. Transferrable protection by gut microbes against STING-associated lung disease.
Platt DJ; Lawrence D; Rodgers R; Schriefer L; Qian W; Miner CA; Menos AM; Kennedy EA; Peterson ST; Stinson WA; Baldridge MT; Miner JJ
Cell Rep; 2021 May; 35(6):109113. PubMed ID: 33979608
[TBL] [Abstract][Full Text] [Related]
2. A Human Gain-of-Function STING Mutation Causes Immunodeficiency and Gammaherpesvirus-Induced Pulmonary Fibrosis in Mice.
Bennion BG; Ingle H; Ai TL; Miner CA; Platt DJ; Smith AM; Baldridge MT; Miner JJ
J Virol; 2019 Feb; 93(4):. PubMed ID: 30463976
[TBL] [Abstract][Full Text] [Related]
3. The IFN-γ receptor promotes immune dysregulation and disease in STING gain-of-function mice.
Stinson WA; Miner CA; Zhao FR; Lundgren AJ; Poddar S; Miner JJ
JCI Insight; 2022 Sep; 7(17):. PubMed ID: 36073546
[TBL] [Abstract][Full Text] [Related]
4. Radioresistant cells initiate lymphocyte-dependent lung inflammation and IFNγ-dependent mortality in STING gain-of-function mice.
Gao KM; Motwani M; Tedder T; Marshak-Rothstein A; Fitzgerald KA
Proc Natl Acad Sci U S A; 2022 Jun; 119(25):e2202327119. PubMed ID: 35696583
[TBL] [Abstract][Full Text] [Related]
5. Lung Inflammation in STING-Associated Vasculopathy with Onset in Infancy (SAVI).
David C; Frémond ML
Cells; 2022 Jan; 11(3):. PubMed ID: 35159128
[TBL] [Abstract][Full Text] [Related]
6. Hierarchy of clinical manifestations in SAVI N153S and V154M mouse models.
Motwani M; Pawaria S; Bernier J; Moses S; Henry K; Fang T; Burkly L; Marshak-Rothstein A; Fitzgerald KA
Proc Natl Acad Sci U S A; 2019 Apr; 116(16):7941-7950. PubMed ID: 30944222
[TBL] [Abstract][Full Text] [Related]
7. STING-Mediated Lung Inflammation and Beyond.
Frémond ML; Crow YJ
J Clin Immunol; 2021 Apr; 41(3):501-514. PubMed ID: 33532887
[TBL] [Abstract][Full Text] [Related]
8. A rare manifestation of STING-associated vasculopathy with onset in infancy: a case report.
Weidler S; Koss S; Wolf C; Lucas N; Brunner J; Lee-Kirsch MA
Pediatr Rheumatol Online J; 2024 Jan; 22(1):9. PubMed ID: 38178067
[TBL] [Abstract][Full Text] [Related]
9. STING inhibitors target the cyclic dinucleotide binding pocket.
Hong Z; Mei J; Li C; Bai G; Maimaiti M; Hu H; Yu W; Sun L; Zhang L; Cheng D; Liao Y; Li S; You Y; Sun H; Huang J; Liu X; Lieberman J; Wang C
Proc Natl Acad Sci U S A; 2021 Jun; 118(24):. PubMed ID: 34099558
[TBL] [Abstract][Full Text] [Related]
10. Activation of Autoreactive Lymphocytes in the Lung by STING Gain-of-function Mutation Radioresistant Cells.
Gao KM; Nündel K; Chiang K; Yin X; Utz PJ; Fitzgerald K; Marshak-Rothstein A
bioRxiv; 2023 Jul; ():. PubMed ID: 37546720
[TBL] [Abstract][Full Text] [Related]
11. STING-associated vasculopathy with onset in infancy: a familial case series report and literature review.
Wang Y; Wang F; Zhang X
Ann Transl Med; 2021 Jan; 9(2):176. PubMed ID: 33569478
[TBL] [Abstract][Full Text] [Related]
12. A novel STING variant triggers endothelial toxicity and SAVI disease.
Valeri E; Breggion S; Barzaghi F; Abou Alezz M; Crivicich G; Pagani I; Forneris F; Sartirana C; Costantini M; Costi S; Marino A; Chiarotto E; Colavito D; Cimaz R; Merelli I; Vicenzi E; Aiuti A; Kajaste-Rudnitski A
J Exp Med; 2024 Sep; 221(9):. PubMed ID: 38953896
[TBL] [Abstract][Full Text] [Related]
13. STING-associated vasculopathy with onset in infancy (SAVI) presenting with skin lesions.
Latour-Álvarez I; Murcia-Clemente L; Vázquez-Pigueras I; Garramone-Ramírez JE; Clemente D; Sanz V; Torrelo A
Pediatr Dermatol; 2024 Apr; ():. PubMed ID: 38682895
[TBL] [Abstract][Full Text] [Related]
14. STING-associated vasculopathy develops independently of IRF3 in mice.
Warner JD; Irizarry-Caro RA; Bennion BG; Ai TL; Smith AM; Miner CA; Sakai T; Gonugunta VK; Wu J; Platt DJ; Yan N; Miner JJ
J Exp Med; 2017 Nov; 214(11):3279-3292. PubMed ID: 28951494
[TBL] [Abstract][Full Text] [Related]
15. Case Report: Novel SAVI-Causing Variants in
Lin B; Torreggiani S; Kahle D; Rumsey DG; Wright BL; Montes-Cano MA; Silveira LF; Alehashemi S; Mitchell J; Aue AG; Ji Z; Jin T; de Jesus AA; Goldbach-Mansky R
Front Immunol; 2021; 12():636225. PubMed ID: 33833757
[TBL] [Abstract][Full Text] [Related]
16. Phenotypic spectrum in recessive STING-associated vasculopathy with onset in infancy: Four novel cases and analysis of previously reported cases.
Wan R; Fänder J; Zakaraia I; Lee-Kirsch MA; Wolf C; Lucas N; Olfe LI; Hendrich C; Jonigk D; Holzinger D; Steindor M; Schmidt G; Davenport C; Klemann C; Schwerk N; Griese M; Schlegelberger B; Stehling F; Happle C; Auber B; Steinemann D; Wetzke M; von Hardenberg S
Front Immunol; 2022; 13():1029423. PubMed ID: 36275728
[TBL] [Abstract][Full Text] [Related]
17. A STING to inflammation and autoimmunity.
Kumar V
J Leukoc Biol; 2019 Jul; 106(1):171-185. PubMed ID: 30990921
[TBL] [Abstract][Full Text] [Related]
18. The activity of disease-causative STING variants can be suppressed by wild-type STING through heterocomplex formation.
Shindo R; Kuchitsu Y; Mukai K; Taguchi T
Front Cell Dev Biol; 2022; 10():1037999. PubMed ID: 36438571
[TBL] [Abstract][Full Text] [Related]
19. 5,6-dimethylxanthenone-4-acetic acid (DMXAA), a partial STING agonist, competes for human STING activation.
Temizoz B; Shibahara T; Hioki K; Hayashi T; Kobiyama K; Lee MSJ; Surucu N; Sag E; Kumanogoh A; Yamamoto M; Gursel M; Ozen S; Kuroda E; Coban C; Ishii KJ
Front Immunol; 2024; 15():1353336. PubMed ID: 38533502
[TBL] [Abstract][Full Text] [Related]
20. The role of cGAS-STING signalling in liver diseases.
Chen R; Du J; Zhu H; Ling Q
JHEP Rep; 2021 Oct; 3(5):100324. PubMed ID: 34381984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
